Prime All Share
9.103,63
PKT
+30,33
PKT
+0,33
%
Werbung
Analysen zu Prime All Share-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.01.25 | Zalando Buy | UBS AG | |
21.01.25 | Siemens Buy | UBS AG | |
21.01.25 | SAP Buy | UBS AG | |
21.01.25 | Infineon Buy | UBS AG | |
21.01.25 | E.ON Buy | UBS AG | |
21.01.25 | CTS Eventim Buy | UBS AG | |
21.01.25 | BMW Buy | UBS AG | |
21.01.25 | Continental Buy | UBS AG | |
21.01.25 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
21.01.25 | Nemetschek Hold | Warburg Research | |
21.01.25 | Drägerwerk Buy | Hauck Aufhäuser Lampe Privatbank AG | |
21.01.25 | Hypoport Buy | Hauck Aufhäuser Lampe Privatbank AG | |
21.01.25 | LANXESS Buy | Warburg Research | |
21.01.25 | SAF-HOLLAND Hold | Deutsche Bank AG | |
21.01.25 | ATOSS Software Buy | Deutsche Bank AG | |
21.01.25 | RATIONAL Hold | Deutsche Bank AG | |
21.01.25 | SAP Buy | Deutsche Bank AG | |
21.01.25 | Kontron Buy | Warburg Research | |
21.01.25 | Airbus Buy | Jefferies & Company Inc. | |
21.01.25 | Nordex Buy | Jefferies & Company Inc. | |
21.01.25 | Scout24 Hold | Jefferies & Company Inc. | |
21.01.25 | BASF Buy | Jefferies & Company Inc. | |
21.01.25 | Bayer Neutral | JP Morgan Chase & Co. | |
21.01.25 | LANXESS Underweight | JP Morgan Chase & Co. | |
21.01.25 | Nemetschek Neutral | Goldman Sachs Group Inc. | |
21.01.25 | Nemetschek Neutral | UBS AG | |
21.01.25 | Fresenius Medical Care (FMC) St. Buy | Goldman Sachs Group Inc. | |
21.01.25 | LANXESS Buy | Goldman Sachs Group Inc. | |
20.01.25 | Nemetschek Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
20.01.25 | Nemetschek Underweight | JP Morgan Chase & Co. | |
20.01.25 | LANXESS Kaufen | DZ BANK | |
20.01.25 | LANXESS Underperform | Jefferies & Company Inc. | |
20.01.25 | Brenntag Underweight | JP Morgan Chase & Co. | |
20.01.25 | Linde Overweight | JP Morgan Chase & Co. | |
20.01.25 | Symrise Overweight | JP Morgan Chase & Co. | |
20.01.25 | K+S Neutral | JP Morgan Chase & Co. | |
20.01.25 | WACKER CHEMIE Neutral | JP Morgan Chase & Co. | |
20.01.25 | LANXESS Underweight | JP Morgan Chase & Co. | |
20.01.25 | Evonik Overweight | JP Morgan Chase & Co. | |
20.01.25 | Covestro Neutral | JP Morgan Chase & Co. |